Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Bayer Pharma describes anticancer agents

Sep. 13, 2016

Sunshine Lake Pharma and Calitor Sciences disclose PI3Kdelta inhibitors

Sep. 13, 2016

SK Biopharmaceuticals patents mGlu5 receptor PAMs

Sep. 13, 2016

Sage Therapeutics announces GABA(A) receptor modulators

Sep. 12, 2016

Incyte presents FGFR-4 inhibitors

Sep. 12, 2016

Bristol-Myers Squibb develops NS5B inhibitors

Sep. 12, 2016

Palobiofarma describes adenosine A2B antagonists and melatonin MT3 receptor ligands

Sep. 12, 2016

Acesys Pharmatech discloses antibacterial agents

Sep. 12, 2016

Ligand Pharmaceuticals patents gemcitabine derivatives

Sep. 12, 2016

Curtana Pharmaceuticals describes new Oligo2 inhibitors

Sep. 9, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...